Cargando…
Fluoroquinolone antibiotics and adverse events
Fluoroquinolones are broad-spectrum antibiotics with good oral bioavailability. They are used for the treatment of a wide variety of infections, but there are restrictions on prescribing these drugs. Epidemiological studies have reported an increased risk of rare adverse effects. These include tendi...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
NPS MedicineWise
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542490/ https://www.ncbi.nlm.nih.gov/pubmed/34728881 http://dx.doi.org/10.18773/austprescr.2021.035 |
_version_ | 1784589441802698752 |
---|---|
author | Baggio, Diva Ananda-Rajah, Michelle R |
author_facet | Baggio, Diva Ananda-Rajah, Michelle R |
author_sort | Baggio, Diva |
collection | PubMed |
description | Fluoroquinolones are broad-spectrum antibiotics with good oral bioavailability. They are used for the treatment of a wide variety of infections, but there are restrictions on prescribing these drugs. Epidemiological studies have reported an increased risk of rare adverse effects. These include tendinopathy and tendon rupture, peripheral neuropathy and aortic aneurysm. Safe prescribing of fluroquinolones requires recognition of patients with risk factors for toxicity. Prompt drug discontinuation is recommended in the event of an adverse reaction. Practising antimicrobial stewardship by prescribing fluoroquinolones only when alternative drugs are unavailable is also key to limiting adverse events and antibiotic resistance. |
format | Online Article Text |
id | pubmed-8542490 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | NPS MedicineWise |
record_format | MEDLINE/PubMed |
spelling | pubmed-85424902021-11-01 Fluoroquinolone antibiotics and adverse events Baggio, Diva Ananda-Rajah, Michelle R Aust Prescr Article Fluoroquinolones are broad-spectrum antibiotics with good oral bioavailability. They are used for the treatment of a wide variety of infections, but there are restrictions on prescribing these drugs. Epidemiological studies have reported an increased risk of rare adverse effects. These include tendinopathy and tendon rupture, peripheral neuropathy and aortic aneurysm. Safe prescribing of fluroquinolones requires recognition of patients with risk factors for toxicity. Prompt drug discontinuation is recommended in the event of an adverse reaction. Practising antimicrobial stewardship by prescribing fluoroquinolones only when alternative drugs are unavailable is also key to limiting adverse events and antibiotic resistance. NPS MedicineWise 2021-10-01 2021-10 /pmc/articles/PMC8542490/ /pubmed/34728881 http://dx.doi.org/10.18773/austprescr.2021.035 Text en (c) NPS MedicineWise https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND) 4.0 License. |
spellingShingle | Article Baggio, Diva Ananda-Rajah, Michelle R Fluoroquinolone antibiotics and adverse events |
title | Fluoroquinolone antibiotics and adverse events |
title_full | Fluoroquinolone antibiotics and adverse events |
title_fullStr | Fluoroquinolone antibiotics and adverse events |
title_full_unstemmed | Fluoroquinolone antibiotics and adverse events |
title_short | Fluoroquinolone antibiotics and adverse events |
title_sort | fluoroquinolone antibiotics and adverse events |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542490/ https://www.ncbi.nlm.nih.gov/pubmed/34728881 http://dx.doi.org/10.18773/austprescr.2021.035 |
work_keys_str_mv | AT baggiodiva fluoroquinoloneantibioticsandadverseevents AT anandarajahmicheller fluoroquinoloneantibioticsandadverseevents |